Clinical Trials Sponsored by Gustavo Oderich

Total 337 results

Gustavo Oderich
William Cook Australia

Recruiting

Complex Abdominal, TAAA, Aortic Arch Aneurysm or Dissections With Fenestrated/Branched Stent Graft

Thoracoabdominal Aortic Aneurysm | Aortic Arch Aneurysm | Complex Abdominal Aortic Aneurysm | Aortic Arch Dissection

United States
Gustavo Oderich
Cook Group Incorporated

Recruiting

Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts

Juxtarenal Aortic Aneurysms | Suprarenal Aortic Aneurysms | Type IV Thoracoabdominal Aortic Aneurysms

United States
Orthopaedie Zentrum Zuerich

Active, not recruiting

Ankle Arthrodesis Nail for 2-level Pathologic Tibial Fracture

Bone Metastases | Bone Lesion | Fracture Nonunion

Switzerland
University of Zurich
Lunge Zuerich

Recruiting

Randomized-controlled Trial of Preoperative Inspiratory Muscle Training on Postoperative Complications (INSPIRA)

Postoperative Complications | Preoperative Period | Breathing Exercises

Switzerland
Roderick van den Bergh

Recruiting

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer (PET-MaN)

Prostate Cancer

Netherlands
Conrad, Erich J., M.D.

Unknown

Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence (VOV-RCT)

Violence
Gustavo Viani Arruda

Completed

Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule

Prostate Cancer

Brazil
Gustavo Rivero
Baylor College of Medicine

Terminated

Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (SS1)

Myelodysplastic Syndromes

United States
Erich Seifritz

Completed

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

Major Depressive Disorder

Switzerland
University Hospital Carl Gustav Carus

Completed

Automated Early Warning Scoring on Surgical Normal Wards

Emergencies | Safety Issues

Germany
University Hospital Carl Gustav Carus

Completed

Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation

Chronic Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Terminated

Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission

Acute Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Unknown

Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Allogeneic Transplantation

Germany
Gustavo Zabert, MD
AstraZeneca

Unknown

PUMA Implementation 2 (IPUMA2)

COPD | Risk Factors | Diagnosis | Spirometry | Adult | Primary Care | Screening Score

Argentina
Conrad, Erich J., M.D.
Forest Laboratories

Completed

Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy

Major Depression | Temporal Lobe Epilepsy

United States
University Hospital Carl Gustav Carus

Completed

Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Germany
University Hospital Carl Gustav Carus

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

Multiple Myeloma | Plasmocytoma

Germany
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer (LySATRA)

Solid Tumor, Adult | Oligometastatic Disease

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence (OSE)

Adults Treated During Childhood or Adolescence for a Malignant Bone Tumor (Osteosarcoma and Ewing Sarcoma)

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Gustave Roussy Cancer Profiling (STING)

Solid Tumor, Unspecified, Adult

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months (REVOCAN)

Ovarian Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas (TORPHYNX)

Squamous Cell Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) (NIVO-ALCL)

Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma

France, Denmark, Netherlands
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma (IMMUQ)

Head and Neck Mucosal Melanomas

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Sequential Analysis in Patients With an Hemopathy (S-HEMO)

Hemopathy

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer (PRINCEPS)

Nonsmall Cell Lung Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia (Sleep-4-All-2)

Cancer | Insomnia

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma (NIVIPIT)

Stage III/IV Melanoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers (PRIMO)

Advanced Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer (PEMBOV)

Ovarian Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Withdrawn

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors (MATILDA)

Metastatic Colorectal Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Prostate Adenocarcinoma | Stomach Adenocarcinoma
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity (ARMONIC)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Withdrawn

Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy (ISILI)

Colorectal Cancer Metastatic

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies (WINTHER)

Metastatic Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer (RAD-THYR)

Thyroid Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma (TSAR)

Soft Tissue Sarcoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck (ELAN-ONCOVAL)

Inoperable Squamous Cell Cancer of the Head and Neck

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers (HPV OncoTect™)

Oropharyngeal Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer (STEREO-SEIN)

Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer (PIPSeN)

Non Small Cell Lung Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Optimized Angiomammography and Comparison With Standard Angiomammography (OPTIAM)

Patients for Whom an Angiomammogram Examination is Requested Whether Its Indication

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients (ProphyloCHIP)

Colorectal Cancer With a Resected Minimal Synchronous PC | Ovarian Metastases | Tumour Rupture in the Abdominal Cavity

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot (GS-OROPHARYNX)

Head and Neck Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer (DOSIMETA)

Thyroid Cancer | Metastases

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine (INPAKT)

Solid Tumors and Non-Hodgkin's Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment (MSN)

Melanoma | Small Cell Lung Cancer | Non Small Cell Lung Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank (BIO-F)

Paediatric Malignancies

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy (BEVIAC)

Colorectal Neoplasms

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Randomized Phase II Study to Assess PD 0332991 in Breast Cancer (POP)

Untreated Operable Early Breast Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Peripheral Primitive Fibromatosis (WS-RT Fibro)

Peripheral Primitive Fibromatosis

France

3

Subscribe